Saakshi Medtech and Panels (NSE:SAAKSHI) Other Financing: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAAKSHI Saakshi Medtech and Panels Ltd NSE:SAAKSHI
50 GF Score
Price ₹345.40
GF Value ₹220.57
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Saakshi Medtech and Panels Other Financing?

Saakshi Medtech and Panels NSE:SAAKSHI -1.43% 50 Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:SAAKSHI with a GF Score™ of 50/100 and a GF Value™ of ₹220.57 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Saakshi Medtech and Panels's Other Financing for the six months ended in Mar. 2026 was ₹0.0 Mil.

Saakshi Medtech and Panels's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Saakshi Medtech and Panels Other Financing Historical Data

* Premium members only.

The historical data trend for Saakshi Medtech and Panels's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saakshi Medtech and Panels Other Financing Chart

Saakshi Medtech and Panels Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial -13.12 -14.59 -16.28 -4.05 -13.48

Saakshi Medtech and Panels Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:SAAKSHI
50GF Score
Saakshi Medtech and Panels Ltd NSE:SAAKSHI
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saakshi Medtech and Panels Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0.0 Mil mean?
Saakshi Medtech and Panels (NSE:SAAKSHI) has a Other Financing of ₹0.0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Saakshi Medtech and Panels and its competitors.
Is Saakshi Medtech and Panels' Other Financing too high?
Saakshi Medtech and Panels' current Other Financing is ₹0.0 Mil. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' Other Financing compare to VRT and BE?
Saakshi Medtech and Panels' Other Financing of ₹0.0 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for an Industrial Products company?
A good Other Financing depends on the Industrial Products industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Saakshi Medtech and Panels and its competitors. Saakshi Medtech and Panels's current Other Financing is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current Other Financing is ₹0.0 Mil. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?

Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued. The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57. GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.

Key valuation signals for NSE:SAAKSHI:

  • Other Financing: ₹0.0 Mil
  • GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
  • GF Score™: 50/100 with 7 warning signs

No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saakshi Medtech and Panels Business Description

Address Plot No. EL-23, J Block, MIDC Industrial Area, Bhosari, Pune, MH, IND, 411026
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score

Get the complete analysis for NSE:SAAKSHI

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹345.40
Price
₹220.57
GF Value